Arrowhead Pharmaceuticals has moved to reassure Wall Street about its deal with Sarepta Therapeutics, telling investors it expects its troubled R&D partner to meet its financial obligations. Sarepta ...
Arrowhead PharmaceuticalsARWR stock tumbled Thursday after Sarepta TherapeuticsSRPT liquefied its entire stake in the smaller biotech company. The beleaguered biotech giant sold more than 9.2 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback